531 – 540 of 3085
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
- Contribution to journal › Article
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
- Contribution to journal › Article
-
Mark
Common traffic routes for imported spermine and endosomal glypican-1-derived heparan sulfate in fibroblasts
- Contribution to journal › Article
-
Mark
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON) : A multicentre, open-label, single-arm, phase 2 trial
- Contribution to journal › Article
-
Mark
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma
- Contribution to journal › Article
-
Mark
DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and −KTS isoforms—From initial observations to recent global genomic analyses
- Contribution to journal › Scientific review
-
Mark
Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer
- Contribution to journal › Article
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
- Contribution to journal › Scientific review
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
- Contribution to journal › Article
